Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Heart AttackEnlarged Heart

Interventions

DRUG

SGLT-2 inhibitors

SGLT2 inhibitor once daily for six months

DRUG

Placebo

Placebo once daily for six months

Trial Locations (1)

RECRUITING

Minneapolis Heart Institute Foundation, Minneapolis

All Listed Sponsors

lead

Minneapolis Heart Institute Foundation

OTHER